Biovie (BIVI) Research & Development (2013 - 2026)
Biovie (BIVI) posted Research & Development of $3.58 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 192.4% from $1.22 million a year earlier and up 12.7% from the prior quarter.
Powered by 
Analysis
Biovie (BIVI) Research & Development (2013 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Biovie's Research & Development came in at $13.96 million, up 50.7% from FY2025.
- Annual Research & Development shows a five-year compound annual growth rate of 40.6% (FY2021 to FY2026).
- In prior fiscal years, Biovie's Research & Development was $9.27 million in FY2025 (-59.9%), $23.1 million in FY2024 (-30.6%), $33.3 million in FY2023 (+92.9%) and $17.26 million in FY2022 (+578.2%).
- Quarterly Research & Development has run from a low of $1.22 million in fiscal Q4 2025 to a high of $11.2 million in fiscal Q3 2023 over five years.
- On a year-over-year basis, Research & Development increased in three of the last eight quarters, with growth averaging 18.1%.
- The strongest year-over-year quarter for Research & Development in the past five years was fiscal Q2 2022, with growth of 402.5%; the weakest was fiscal Q1 2025, with a decline of 77.6%.
- According to Business Quant data, Research & Development for the three prior fiscal quarters was $3.18 million (Q3 2026), $4.27 million (Q2 2026) and $2.94 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Biovie | 11.62 Mn | 11.62 Mn | - | 3.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.58 Mn |
| Mar 31, 2026 | 3.18 Mn |
| Dec 31, 2025 | 4.27 Mn |
| Sep 30, 2025 | 2.94 Mn |
| Jun 30, 2025 | 1.22 Mn |
| Mar 31, 2025 | 1.34 Mn |
| Dec 31, 2024 | 4.70 Mn |
| Sep 30, 2024 | 1.99 Mn |
| Jun 30, 2024 | 2.05 Mn |
| Mar 31, 2024 | 5.70 Mn |
| Dec 31, 2023 | 6.47 Mn |
| Sep 30, 2023 | 8.88 Mn |
| Jun 30, 2023 | 8.30 Mn |
| Mar 31, 2023 | 11.20 Mn |
| Dec 31, 2022 | 7.03 Mn |
| Sep 30, 2022 | 6.77 Mn |
| Jun 30, 2022 | 5.87 Mn |
| Mar 31, 2022 | 3.58 Mn |
| Dec 31, 2021 | 4.71 Mn |
| Sep 30, 2021 | 3.09 Mn |
API Access
Biovie Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=BIVI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "BIVI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=BIVI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();